In summary, abnormally low O‐GlcNAcylation levels significantly promote the initiation and progression of AD by regulating key events including Tau phosphorylation, Aβ production, neuroinflammatory responses, and insulin signaling. Here, MAPT is linked to Alzheimer disease.